"10.1371_journal.pone.0022476","plos one","2011-07-18T00:00:00Z","Lars Haukali Omland; Peer Brehm Christensen; Henrik Krarup; Peter Jepsen; Nina Weis; Henrik Toft SÃ¸rensen; Niels Obel; on behalf of the DANVIR Cohort Study","Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark; Department of Clinical Biochemistry, Aarhus University Hospital, Aalborg Hospital, Aalborg, Denmark; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark; Department of Medicine V (Hepatology and Gastroenterology), Aarhus University Hospital, Aarhus, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre Hospital, Copenhagen, Denmark; Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America","Conceived and designed the experiments: LHO PBC HK PJ NW HTS NO. Performed the experiments: LHO. Analyzed the data: LHO. Contributed reagents/materials/analysis tools: PBC HK PJ NW HTS NO. Wrote the paper: LHO PBC HK PJ NW HTS NO.","The author has read the journal's policy and has the following conflicts: Grants received: NO (Roche, Bristol-Meyers Squibb, Merck Sharp & Dohme, GlaxoSmithKline, Abbott, Boehringer Ingelheim, Janssen-Cilag, Swedish-Orphan Drugs). PBC (Roche, Scheering-Plough). Honoria for speaking at meetings: LHO (Tibotec and Merck Sharp & Dohme). All other authors: no conflicts. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","07","Lars Haukali Omland","LHO",8,TRUE,7,1,1,7,TRUE,TRUE,TRUE,1,"8",TRUE
